| NDC Code | 0597-0164-90 |
|---|
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0597-0164-90) |
|---|
| Product NDC | 0597-0164 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Glyxambi |
|---|
| Non-Proprietary Name | Empagliflozin And Linagliptin |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20150130 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA206073 |
|---|
| Manufacturer | Boehringer Ingelheim Pharmaceuticals, Inc. |
|---|
| Substance Name | EMPAGLIFLOZIN; LINAGLIPTIN |
|---|
| Strength | 25; 5 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA] |
|---|